Latest posts
-
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market
WARREN, N.J., Nov. 29, 2023 — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that the staff of NYSE Regulation (the “NYSE Regulation”) has determined to immediately suspend trading in the Company’s common
-
PRISM MediaWire – Weekly Press Resume – Nov. 6 to Nov. 10, 2023
New York, New York, Nov. 10, 2023 PRISM MediaWire – Weekly Press Resume Nov. 6 to Nov. 10, 2023 Two Hands Corporation Launches Sports Illustrated Line Protein Bars in Canada BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023 Evergreen Group unveils new corporate haven in M’sia with HWG partnership
-
Lipella Pharmaceuticals Granted FDA Orphan Designation for Oral Graft-versus-Host Disease Drug
“GvHD affects approximately 30,000 Americans and oral GvHD causes significant oral pain and discomfort, making it difficult for patients to eat, drink and speak. Oral GvHD is a great unmet need in cancer survivors.” Dr. Michael Chancellor, Chief Medical Officer at Lipella Pharmaceuticals Pittsburgh, PA, November 10, 2023 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,”
-
PRISM MediaWire – Weekly Press Resume – Oct. 30 to Nov. 3, 2023
New York, New York, Nov. 3, 2023 PRISM MediaWire – Weekly Press Resume Oct. 30 to Nov. 3, 2023 Metatron Pioneers Real-Time Stock Insights with AI-Enhanced Stock Trendz PRISM MarketView Highlights Its Spooktacular Zombie Index For Halloween Franklin Mining Bolivia (a branch of Franklin Mining, Inc.) and Rockin’ G Gold Form New Joint Venture for
-
PRISM MediaWire – Weekly Press Resume – Oct. 23 to Oct. 27, 2023
New York, New York, October 27, 2023 PRISM MediaWire – Weekly Press Resume Oct. 23 to Oct. 27, 2023 Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference Metatron Partners with MML Marketing, Boasting a Proven Track Record of $19M in Sales Argentum 47, Inc. Moves into Online Cloud Business with New SaaS
-
Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference
Pittsburgh, PA, October 23, 2023 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our, “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, will present at the 2023 virtual Fall Foliage MicroCap Rodeo Conference to be held from October 24th – 27th. Dr. Jonathan Kaufman, CEO of Lipella, said: “2023